Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
At the time the article was last revised Frank Gaillard had the following disclosures:
- Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
- Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)
These were assessed during peer review and were determined to not be relevant to the changes that were made.View Frank Gaillard's current disclosures
Synaptophysin is a membrane glycoprotein found in presynaptic vesicles and is commonly used as an immunohistochemical marker for cells of neuronal (e.g. gangliogliomas) and neuroendocrine lineage (e.g. pheochromocytomas and paragangliomas) 1,2.
In the brain, it has been suggested that perisomatic synaptophysin immunohistochemical staining is not seen in normal neurons and therefore is a reliable feature to distinguish neoplastic from non-neoplastic neurons. It appears, however, that this is not always the case; normal brain, as well as non-neoplastic brain tissue, can show synaptophysin staining 3.